StockUK listing UK0MSDLSEValue Trap

CompuGroup Medical AG O.N.(0MSD) Stock Analysis

EUR --+0.00%
Reward40Moderate
Risk49Moderate
75%Data
Thin 2% profit margin
EUR —+0.00 (+0.00%) Previous close · LSE
Market cap 2.01Bn
Reward Ratingⓘ40 Moderate reward assessment · 75% data coverage
Bottom 10% of stocksView factors
Risk Ratingⓘ49 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on 0MSD to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is CompuGroup Medical AG O.N.?

KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally.

AI Brief Pro

The brief on CompuGroup Medical AG O.N.

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is CompuGroup Medical AG O.N.?

KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The company is listed on the LSE in UK, with a market capitalisation of 2.01B, and a P/E ratio of 28.7x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Adequate profitability with some margin variability in recent periods.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Discount reflects uncertainty around future performance.

OpenBook Logo Analysis

Reward: Moderate (40)
Company Information
SectorN/A
IndustryN/A
P/E Ratio28.7396
Beta0.721
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.